13F
← All fund report cards

ArrowMark Colorado Holdings LLC

13F equity value
$3.8B
Positions
293
Top 10 concentration
18.4%
Quarters / total new picks
32 / 428
13F equity value over time
$0M$7B$13B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.8% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 46.9% of quarters (excess t = -0.69, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-1.0%
t-stat
-0.69
Quarterly win rate
47%
Annualized excess
-1.2%
$1 → follow vs universe
$1.91 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.00620180630: follow 0.97420180930: follow 1.13820181231: follow 1.11120190331: follow 1.01920190630: follow 1.13820190930: follow 1.25020191231: follow 0.93520200331: follow 1.10220200630: follow 1.19720200930: follow 1.48420201231: follow 1.53320210331: follow 1.50920210630: follow 1.74720210930: follow 1.62520211231: follow 1.32020220331: follow 1.40220220630: follow 1.23020220930: follow 1.31920221231: follow 1.36020230331: follow 1.37420230630: follow 1.16020230930: follow 1.40420231231: follow 1.30220240331: follow 1.34320240630: follow 1.48720240930: follow 1.55820241231: follow 1.36820250331: follow 1.66720250630: follow 1.56020250930: follow 1.81920251231: follow 1.906 0.84 1.54 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 293 · 2026 Q1

Ticker Value Weight QoQ
BIL $116M
3.1%
TRIM
FSS $67M
1.8%
ADD
TRMB $67M
1.8%
TRIM
RBA $65M
1.7%
ADD
TPB $65M
1.7%
TRIM
CHDN $64M
1.7%
ADD
AXGN $63M
1.7%
ADD
KEX $63M
1.7%
TRIM
HNGE $61M
1.6%
ADD
CW $60M
1.6%
TRIM
TNDM $59M
1.6%
ADD
VNOM $58M
1.5%
TRIM
WAY $53M
1.4%
ADD
CMPR $49M
1.3%
TRIM
COO $47M
1.3%
TRIM
VST $47M
1.3%
HOLD
VCYT $44M
1.2%
TRIM
CARG $44M
1.2%
TRIM
SPXC $43M
1.2%
ADD
SARO $43M
1.1%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.